随着人口结构变化、疾病谱系变迁以及民众对健康品质需求的不断提升，单纯以疾病治疗为中心的医疗 模式已不能满足多元化的健康需求。社会办医作为公立医疗服务体系的重要补充，在这场变革中扮演着 愈发关键的角色。其中，由保险资本主导的医疗集团，因其独特的资源禀赋与商业模式，被视为重塑产 业格局的重要变量。 北大医疗作为这一领域的先行者与代表性机构，具有双重基因：一是源自北京大学医学部逾百年的深厚 学术底蕴、严谨医风与顶尖人才体系，这是其医疗品质的压舱石；二是来自中国平安集团的综合金融资 源、科技创新能力与庞大客户生态，这是其模式创新的推进器。两种不同的基因如何真正融合？险资办 医如何平衡医疗本质与市场逻辑？在医疗健康产业变革的十字路口，北大医疗如何走出一条可持续的创 新之路？针对上述问题，近日，《金融时报》记者对北大医疗董事长、平安健康险董事长兼首席执行官 朱友刚进行了专访。 《金融时报》记者：北大医疗所实践的"保险+医疗"模式，最根本的优势与核心的挑战是什么？在实践 中，北大医疗如何用好"北大底蕴"与"平安特色"？ 朱友刚：首先谈优势。险资办医，尤其是背靠大型综合金融集团办医，核心优势在于两个方面。一是构 建"支付+服 ...

随着人口结构变化、疾病谱系变迁以及民众对健康品质需求的不断提升，单纯以疾病治疗为中心的 医疗模式已不能满足多元化的健康需求。社会办医作为公立医疗服务体系的重要补充，在这场变革中扮 演着愈发关键的角色。其中，由保险资本主导的医疗集团，因其独特的资源禀赋与商业模式，被视为重 塑产业格局的重要变量。 北大医疗作为这一领域的先行者与代表性机构，具有双重基因：一是源自北京大学医学部逾百年的 深厚学术底蕴、严谨医风与顶尖人才体系，这是其医疗品质的压舱石；二是来自中国平安集团的综合金 融资源、科技创新能力与庞大客户生态，这是其模式创新的推进器。两种不同的基因如何真正融合？险 资办医如何平衡医疗本质与市场逻辑？在医疗健康产业变革的十字路口，北大医疗如何走出一条可持续 的创新之路？针对上述问题，近日，《金融时报》记者对北大医疗董事长、平安健康险董事长兼首席执 行官朱友刚进行了专访。 《金融时报》记者：北大医疗所实践的"保险+医疗"模式，最根本的优势与核心的挑战是什么？在 实践中，北大医疗如何用好"北大底蕴"与"平安特色"？ 朱友刚：首先谈优势。险资办医，尤其是背靠大型综合金融集团办医，核心优势在于两个方面。一 是构建"支付+服 ...

00:16 华声在线2月1日讯（全媒体记者 仝若楠）2月1日，出席湖南省政协十三届四次会议的委员们怀揣民生 期许、带着精心打磨的提案，陆续抵达会议驻地，向大会报到。 报道现场秩序井然，工作人员提前到位，签到表、出席证、文件袋等物料摆放整齐。委员们在现场工作 人员的引导下有条不紊办结报到手续、领取资料。完成报到后，委员们手拿会议材料仔细阅读，或相互 交流履职心得、或热议家乡的新变化。 来源：华声在线 今年省两会，省政协委员李洪梅将聚焦家乡的发展变化，呼吁加快推进永清高速（江华至连山段）项 目，方便省内外企业交流。 省政协委员刘东波重点关注低空经济与大众健康。他表示："单纯药物治疗已无法覆盖全民健康需求， 非药物干预愈发重要，通过运动处方、营养处方结合数字医疗，推动公众从被动治病转变为主动健康管 理，做好自我健康调节。" ...

新华财经上海1 月 30日电（记者 王淑娟）平安健康险最新发布的2025年理赔年度报告显示，2025年平 安健康险累计理赔案件达622万个，理赔客户171万人，赔付总金额达79亿元，人均赔付4次，单客户最 高赔付金额456万元。其中，最快理赔仅需3秒，实现了理赔效率的再提速，单客户最长赔付年限跨越17 年，见证了治疗周期中的持续守护，赔付年龄跨度从13天到103岁，实现了全生命周期的保障覆盖。 值得关注的是，截至2025年底，平安健康险的肿瘤全病程服务已累计服务39.6万人次，精准就医引导达 1.4万人次，就医服务达35万人次，特药使用14.4万人次，康复服务1.1万人次。报告显示，肿瘤全病程 服务最长时长记录达1460天，单人最多特药使用46次，单笔特药赔付金额最高达129万元。 理赔数据也是健康风险趋势的晴雨表，平安健康险2025年理赔年报揭示了三大趋势，不仅关乎个体保障 规划，也为产品与服务创新指明方向。年报显示，院外药品费用持续攀升。2025年，客户特药使用人次 涨幅达105%，特药账单总金额同比增长50%，人均账单同比上涨10%。 此外，跨省异地就医人数逐年增长。2025年客户异地就诊人数占比已达8 ...

朱友刚表示，这一成绩的取得，与北大医疗创新构建的"健-医-康"全周期服务闭环密切相关。面对医疗 服务领域长期存在的"重医不重防、检出无人问、院后无人管"痛点，该模式通过联动健康管理、综合医 疗与康复照护三大板块，实现"检医一体、医康衔接"，推动服务从被动治疗转向主动健康管理。 据介绍，集团依托"北大底蕴"与"平安特色"双轮驱动，通过"管理+学科+科研+品牌"四维赋能，实现了 逆势增长。具体来说，在健康管理端，北大医疗基于平安大数据与专业风险评估，为客户提供定制化筛 查方案与会员制家庭健康管理服务；在综合医疗端，依托北京大学医学部顶尖专家团队与多学科协作诊 疗（MDT）模式，提供一站式精准诊疗，其国际医疗部已服务来自43个国家的患者；在康复照护端， 则将服务延伸至家庭场景，构建临床与康复高度融合的生态。 中证报中证网讯（记者 李静）在1月22日举行的第二届北大医疗集团开放日活动上，北大医疗集团董事 长朱友刚表示，2025年集团业绩实现稳健增长，其中非医保收入增速达35%，门急诊人次突破320万人 次，三四级手术量同比增长20%，门诊患者满意度、住院患者满意度双双创下历史最佳纪录。 值得注意的是，北大医疗依托中国 ...

Core Insights - The Chinese pet economy is experiencing a significant transformation, evolving from a simple interest to a mainstream lifestyle, with a shift from "dog and cat dominance" to a more diversified market structure that includes various pets [1][3] Group 1: Market Trends - By 2025, the number of urban dogs and cats in China is projected to reach 126 million, with a year-on-year growth of 1.8% [1] - The urban pet consumption market is expected to reach 312.6 billion yuan in 2025, reflecting a 4.1% increase from 2024 [5] - The market is transitioning from a phase of quantity growth to a focus on quality, with an emphasis on "refined pet care" [5][6] Group 2: Consumer Behavior - Pet owners are increasingly viewing their pets as family members and emotional companions, leading to a rise in personalized pet care and unique pet ownership experiences [4] - The demand for non-traditional pets, such as reptiles and aquatic animals, is growing, indicating a shift towards individual expression and community identity among younger pet owners [4] Group 3: Challenges in Services - There are significant service gaps in the pet care industry, particularly in areas such as veterinary care and pet travel, with 48.1% of pet owners citing high medical costs and 28.9% facing difficulties in traveling with pets [2][7] - The pet insurance market is facing challenges, with issues related to claims processing and high payout rates leading to a "win-win" situation for neither pet owners nor insurance companies [9][11] Group 4: Future Directions - The pet industry must address the mismatch between rapidly evolving consumer expectations and the current level of service provision, particularly in pet travel and healthcare [7][8] - To improve the pet insurance landscape, the industry needs to innovate products and establish a transparent medical data system to enhance trust and streamline claims processes [12]

Core Insights - The article discusses the launch and growth of Ant Group's AI health application, Antifuku, highlighting the shift in user demand from "treatment" to "health management" as a result of rising health awareness and the "Healthy China" strategy [1][2][4] Group 1: Market Trends and User Insights - Antifuku has achieved over 15 million monthly active users within six months of launch, indicating a strong market interest in proactive health management [2] - The user base shows a significant presence from lower-tier cities, with 55% of users coming from these areas, suggesting a growing demand for accessible health services in regions with fewer medical resources [2] - The application has evolved from a focus on medical needs to addressing everyday health inquiries, reflecting a broader societal trend towards proactive health management [4][5] Group 2: Product Development and Strategy - Ant Group's health division has been integrated into its strategic pillars alongside digital payment and finance, emphasizing the importance of health services in its overall business model [6] - The company plans to enhance Antifuku's capabilities by focusing on personalization, professionalism, and automation, aiming to provide tailored health advice through partnerships with smart device manufacturers [7] - Antifuku currently does not consider commercialization, ensuring that its health advice remains free from advertising influences, which is crucial for maintaining user trust [8] Group 3: AI and Healthcare Collaboration - The application aims to assist rather than replace human doctors, helping to alleviate the burden of routine inquiries and allowing healthcare professionals to focus on more complex cases [9][10] - Antifuku has established collaborations with over 500 medical professionals, including six academicians, to enhance the quality of its AI-driven health consultations [10] - The company emphasizes the importance of user experience, incorporating features that cater to various demographics, including older users, to ensure accessibility and engagement [9]

Core Viewpoint - The article emphasizes the urgent need for a proactive health management system in response to the challenges posed by an aging population, the rise of chronic diseases among younger individuals, and the imbalance in medical resource supply and demand. The traditional reactive medical model is no longer sustainable, highlighting the importance of continuous and dynamic health data management [1][2]. Group 1: Industry Challenges and Opportunities - The current bottleneck in health management is the lack of a continuous, dynamic, and intervenable data loop, with traditional health check-ups being insufficient to capture subtle health changes [2]. - The aging population and the increasing prevalence of chronic diseases necessitate a shift from a disease-centered approach to a more comprehensive health management strategy [1][2]. Group 2: Solutions and Innovations - Huawei's Qingtian Cloud has introduced three "universal" solutions to address the core pain points in health management, creating a seamless health network that covers home, community, institutions, and workplaces [2]. - The Shandong Xinyue Health Technology Co., Ltd. has developed a smart health management solution using Huawei's wearable devices, which continuously collects vital signs and integrates them with static medical data to create a complete "digital life portrait" [2]. - The Hebei Zhixing Health Management Service Co., Ltd. has implemented a community health management solution that allows users to monitor key health indicators through Huawei's wearable devices, enhancing health literacy and reducing the burden on hospitals [3]. Group 3: Vertical Scene Development - Huawei's Qingtian Cloud has successfully implemented a "stroke risk monitoring management" system in collaboration with Nantong University Affiliated Hospital, utilizing high-precision monitoring and AI algorithms for emergency responses [5]. - The "general practitioner health management" initiative at Central South University Xiangya Third Hospital extends health management to family units, promoting proactive health maintenance [5]. - The "healthy lifestyle management" program at the Chinese Academy of Medical Sciences Fuwai Hospital focuses on personalized and intelligent health interventions based on evidence-based medicine [5]. Group 4: Industry Standards and Future Directions - The summit highlighted the importance of establishing industry standards, such as the "smart follow-up platform wearable data access standard," which has gained recognition and aims to bridge the gap between consumer-grade hardware and medical applications [7]. - The digital transformation in health management is deemed essential for improving resource accessibility and chronic disease management efficiency, with Huawei's Qingtian Cloud facilitating a shift from experience-driven to data-driven approaches [7]. - The future vision includes building a comprehensive proactive health ecosystem that empowers individuals to take responsibility for their health, supported by open ecosystems and standardized interfaces [7].

随着"十五五"规划纲要的逐步推进，实施健康优先发展战略已不再仅仅是政策层面的宏伟蓝图，而是成为了社会发展的时代强音。在人口老龄化加剧与慢性 病年轻化双重压力交织的当下，行业内部关于"防、治、康、管"全链条服务体系的建设虽已达成共识，但在具体的执行层面，依然面临着"落地难"的困境。 如何填补院外监测空白、打破数据孤岛，将"主动健康"从一句响亮的口号转化为可执行、可复制的实操样本，成为了整个医疗健康产业亟待破解的必答题。 就在 12 月 25 日，于深圳召开的第二届华为终端健康管理行业峰会，为这一行业难题给出了一份极具分量的"答卷"。 会上，华为擎云携手众多行业合作伙伴，重磅亮相了六大健康管理解决方案及标杆案例。这不仅是一次产品与技术的集中展示，更被业界视为主动健康管理 从观念倡导迈向实质性落地实践的里程碑事件。 华为擎云正试图通过商用终端与数字化能力的深度结合，构建坚实的"数字底座"，助力健康管理产业完成从人力密集型向"技术 + 服务"双轮驱动型的关键跃 迁。 重构全域服务，数智底座打破数据孤岛 长期以来，传统医疗服务体系面临着严峻的供需失衡挑战。院内治疗与院外管理之间存在着巨大的数据鸿沟，导致患者依从性差、干 ...

Core Insights - The Chinese health consumption market is undergoing a significant structural transformation, with consumers shifting from a traditional "seek medical help only when sick" approach to proactive health management throughout their life cycle [1] - This shift is driven by increased public health risk awareness, enhanced consumer health cognition, and factors such as digital technology proliferation, policy guidance, and demographic changes [1] - Companies in the health consumption sector must quickly identify and address the pain points faced by Chinese consumers in proactive health management, which requires keen insight and systematic innovation [1] Industry Trends - Bayer's Health Consumer Division is breaking away from the conventional "global formula introduction" and "mature model replication" strategies, focusing instead on localized solutions that meet the unique demands of Chinese consumers [2] - In 2025, Bayer launched innovative health solutions tailored to local needs, enhancing its product portfolio and contributing to the high-quality development of the Chinese health consumption market [2] Health Issues Addressed - Allergic rhinitis is a growing public health issue in China, with self-reported cases increasing by nearly 100 million from 2005 to 2011 [5] - The prevalence of allergic rhinitis among children rose from 14.81% (2001-2011) to 19.75% (2012-2021), indicating a concerning trend [5] - Bayer is focusing on allergic conditions, launching new products like the mometasone nasal spray in 2025 to better meet the needs of patients [5] Product Innovations - Bayer introduced the Daxin® lactulose oral solution in collaboration with JD Health to address chronic constipation, which affects approximately 140 million adults in China [6][7] - The company also launched the upgraded Bepanthen B5 cream for babies, designed to protect sensitive skin, showcasing a shift from global formulas to products specifically developed for Chinese consumers [7] Collaborative Innovation - Bayer is establishing a "co-creation platform" to foster open innovation, moving away from traditional closed R&D models [10] - The Bayer China Innovation Cooperation Center, launched in October 2024, aims to integrate local research with global resources to accelerate the transformation of scientific advancements into consumer health solutions [10][12] Market Strategy - Bayer's strategy has evolved from merely importing foreign products to co-creating solutions based on Chinese consumer needs, as seen in products like One A Day fish oil and Alevin children's calcium [13] - The company emphasizes a proactive approach to health management, focusing on prevention and scientific intervention rather than just treatment [14] Global Impact - Bayer's innovations in China are not only enhancing local health management but are also being recognized globally, with successful products entering the Asia-Pacific market and beyond [17][18] - The company's commitment to leveraging local insights for global competitiveness highlights China's role as a source of innovation in the health consumption sector [18][19]